Brief: Ryvu Therapeutics Q2 Net Loss Widens To 24.2 Mln Zlotys
08/09/2021 16:33
Sept 8 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q2 NET LOSS 24.2 MILLION ZLOTYS VERSUS LOSS OF 4.3 MILLION
ZLOTYS YEAR AGO
* Q2 REVENUE 5.5 MILLION ZLOTYS VERSUS 10.8 MILLION ZLOTYS
YEAR
AGO
Source text for Eikon: ID:nEM9vQ8QPa
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project